Akebia Therapeutics, Inc. announced the appointment of Myles Wolf to its Board of Directors, effective April 6. Wolf serves as Chief of the Division of Nephrology and a Professor of Medicine at Duke University School of Medicine. Dr. Wolf replaces Jodie P. Morrison who resigned from the Board, effective April 3.